0001140361-23-023198.txt : 20230505 0001140361-23-023198.hdr.sgml : 20230505 20230505160452 ACCESSION NUMBER: 0001140361-23-023198 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230503 FILED AS OF DATE: 20230505 DATE AS OF CHANGE: 20230505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCLAUGHLIN KEVIN F CENTRAL INDEX KEY: 0001214938 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35280 FILM NUMBER: 23893723 MAIL ADDRESS: STREET 1: C/O ACCELERON PHARMA INC. STREET 2: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vericel Corp CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7349305555 MAIL ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC DATE OF NAME CHANGE: 19960428 4 1 form4.xml X0407 4 2023-05-03 0000887359 Vericel Corp VCEL 0001214938 MCLAUGHLIN KEVIN F C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE MA 02139 true false Stock Option (right to buy) 32.12 2023-05-03 4 A 0 8000 0 A 2033-05-03 Common Stock 8000 8000 D Restricted Stock Unit 2023-05-03 4 A 0 3200 0 A Common Stock 3200 3200 D The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. These RSUs vest 100% on the earlier of May 3, 2024 or the date of the first Annual Meeting of Stockholders following May 3, 2023. No expiration date for this type of award. /s/ Sean Flynn, as Attorney-in-Fact for Kevin McLaughlin 2023-05-05